MYO Armband®联合定制视频游戏用于多发性硬化上肢康复的成本效果分析
本研究基于随机对照试验,从医疗提供者视角分析MYO Armband®手势传感器联合定制严肃游戏用于多发性硬化患者上肢康复的成本效果。结果显示实验组总费用为6,240.4欧元,对照组为5,721.1欧元,干预使患侧主动关节活动度改善的增量成本效果比具有统计学意义。
要点
- 实验组总费用6,240.4欧元,对照组5,721.1欧元,每患者成本差35欧元。
- 患侧掌屈每改善1级增量成本7.5欧元,旋前13.5欧元,旋后5.4欧元,均具统计学意义。
- 背屈每改善1级增量成本6.2欧元,但差异无统计学意义。
核心结论
- MYO Armband®联合定制视频游戏用于多发性硬化患者上肢康复,以相对适度的额外成本维持上肢关节活动度,初步显示具有成本效果。
研究设计与样本
- 随机对照试验,样本随机分为实验组(MYO Armband®手势传感器控制的严肃游戏加常规治疗)和对照组(常规治疗)。
- 两组均每周2次、每次60分钟,共8周;在治疗前、治疗后及2周无治疗随访期评估腕和前臂关节活动度、握力、协调性和上肢粗大灵巧性。
- 从医疗提供者视角识别、测量和评估多场景资源使用,比较基线与随访结束时的健康结局差异和直接医疗成本,估算增量成本效果比(ICER)。
主要发现
- 对照组总费用为5,721.1欧元,实验组为6,240.4欧元,干预与对照之间的成本差为每患者35欧元。
- MYO Armband®干预在患侧主动关节活动度上显示有利的成本效果比:掌屈每增加1级(度)额外花费7.5欧元,旋前额外13.5欧元,旋后额外5.4欧元,均具有统计学意义。
- 背屈每增加1级增量成本为6.2欧元,但该差异无统计学意义。
- 治疗依从性(百分比)每增加1个百分点的增量成本为5.9欧元。
关键数值与推荐
- 患侧掌屈每改善1级增量成本7.5欧元(具统计学意义)。
- 患侧旋前每改善1级增量成本13.5欧元(具统计学意义)。
- 患侧旋后每改善1级增量成本5.4欧元(具统计学意义)。
- 患侧背屈每改善1级增量成本6.2欧元(差异无统计学意义)。
- 治疗依从性每增加1个百分点增量成本5.9欧元。
临床怎么用
- 对于多发性硬化上肢功能障碍患者,可考虑在常规治疗基础上加用MYO Armband®联合定制视频游戏,以较小增量成本改善患侧关节活动度。
- 临床决策时可参考患侧掌屈、旋前、旋后每改善1级的增量成本数据,结合患者具体情况评估经济性。
局限性
- 原文未报告样本量、置信区间和P值等详细统计信息。
- 作者指出这些为初步结果,尚需未来研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The rapid and extensive expansion of virtual reality (VR) across all medical specialties, including neurorehabilitation, has significantly enhanced and broadened the treatment options for individuals with neurological disorders. The objective of the present study was to carry out an economic analysis of the MYO Armband® device in combination with specifically designed video games for upper limb (UL) rehabilitation in people with multiple sclerosis (MS). METHODS: A randomized controlled trial was conducted. The sample was randomly assigned to two groups: an experimental group (EG) that received UL rehabilitation through serious games developed by the research team and controlled with the MYO Armband® gesture sensor plus conventional therapy, and a control group (CG) that received conventional therapy. Both groups underwent two 60-minute sessions per week for eight weeks. Wrist and forearm range of motion, grip muscle strength and coordination and gross UL dexterity were evaluated pre-treatment, post-treatment and during a follow-up period of 2 weeks without receiving any treatment. Also, satisfaction and compliance (attendance) were recorded in both groups. The healthcare provider's perspective was used to identify, measure, and assess resource use across multiple scenarios. Differences in health outcomes and direct healthcare costs were compared from baseline to the end of follow-up in both groups. The aim was to estimate the incremental cost-effectiveness ratio (ICER) in order to assess the efficiency of the MYO Armband in improving participants' health outcomes. RESULTS: The total costs in the CG amounted to 5,721.1 euros compared to 6,240.4 euros for the EG, with a cost difference between intervention and control of 35 euros per patient. The MYO Armband® intervention showed a favorable cost-effectiveness ratio on the more affected side in the active range of motion, with statistically significant gains costing 7.5 euros extra per point (grade) increment in palmar flexion, 13.5 euros extra in pronation, and 5.4 euros extra in supination. One additional point (grade) gained in dorsiflexion had an incremental cost of 6.2 euros, although this difference was not statistically significant. Furthermore, the incremental costs for gaining one point in treatment adherence (percentage) were 5.9 euros. CONCLUSION: The use of MYO Armband® in the therapy of patients with MS offers promising results in maintaining their range of motion of the UL at a relatively modest additional cost. While these preliminary results will need to be corroborated by future works, the intervention appears to be cost-effective. Trial registration This randomised controlled trial has been registered at ClinicalTrials.gov Identifier: NCT04171908.
引用
- Marcos-Antón S, Cano-de-la-Cuerda R, Aranda-Reneo I, et al. Cost-effectiveness analysis of the MYO Armband® device in combination with specifically designed video games for upper limb rehabilitation in people with multiple sclerosis. J Neuroeng Rehabil. 2025. PMID: 41299524. doi:10.1186/s12984-025-01801-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。